Document is current
Any future updates will be listed below
-
Authors
Haq, Mariam
Sampath, Vanitha
Sheffield, Perry
Jackson, Richard J.
Nadeau, Kari C. https://orcid.org/0000-0002-2146-2955
- License Information
-
More Information
Article History
Received: 2 March 2024
Revised: 25 September 2024
Accepted: 4 October 2024
First Online: 8 November 2024
Competing interests
: K.C.N. currently reports grants from National Institute of Allergy and Infectious Diseases (NIAID), National Heart, Lung, and Blood Institute (NHLBI), National Institute of Environmental Health Sciences (NIEHS); Stock options from IgGenix, Seed Health, ClostraBio, Cour, Alladapt; Consultant for Excellergy, Red tree ventures, Regeneron, and IgGenix; Co-founder of Alladapt, Latitude, and IgGenix; National Scientific Committee member at Immune Tolerance Network (ITN), and National Institutes of Health (NIH) clinical research centers; patents include, “Mixed allergen com-position and methods for using the same,” “Granulocyte-based methods for detecting and monitoring immune system disorders,” and “Methods and Assays for Detecting and Quantifying Pure Subpopulations of White Blood Cells in Immune System Disorders.” V.S., M.H., P.S., and R.J. declare no COI.
